Study ID | Age range | Breast density (ACR) | Months since dx | Group | Abnormality | Detected by | BI-RADS | Histology | TNM | ER | PR | HER 2 neu |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 50 s | C | 25 | 1 | Ca + | MG only | 4A | DCIS, intermediate nuclear grade Initial ca: IDC, ER-Her + | - | |||
2 | 80 s | B | 216 | 2 | Mass | A-MRI only | 4B | DCIS, high nuclear grade Initial ca: DCIS | - | |||
3 | 40 s | C | 37 | 2 | Mass | A-MRI only | 4B | IDC, grade 2/3 Initial ca: IDC, ER + Her- | T1c N0 M0 | + | + | - |
4 | 60 s | C | 144 | 2 | NME | A-MRI only | 4B | Microinvasive lobular carcinoma, Pleomorphic lobular carcinoma in situ Initial cancer: IDC, TN | T1miN0 M0 | |||
5 | 30 s | C | 7 | 2 | Mass | A-MRI only | 5 | IDC, grade 3/3 Initial ca: IDC, ER + Her + | T3 N2 M0 | - | - | + |
6 | 70 s | C | 120 | 2 | Mass | A-MRI only | 5 | IDC, grade 2/3, DCIS Initial Ca: IDC, TN | T2 Nx | + | - | - |
7 | 50 s | B | 33 | 2 | Mass (lung) | A-MRI only | N/A | Adenocarcinoma consistent with breast cancer Initial ca: IDC, ER + Her- | - | + | + | - |